KLC
AMED

Kent Lake Capital’s Amedisys AMED Stock Holding History

Kent Lake Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$5.26M – 39
2022
Q2 		$5.26M Buy
50,000
+20,000
+67% +$2.56M 2.89% 14
2022
Q1 		$5.17M Buy
+30,000
New +$4.48M 3.21% 14
2021
Q4 		– Sell
-12,849
Closed -$1.92M – 38
2021
Q3 		$1.92M Buy
+12,849
New +$2.67M 0.82% 28

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kent Lake Capital's AMED Position: Q3 2022 in Review

Kent Lake Capital sold out of Amedisys (AMED) in Q3 2022, closing a stake of 50,000 shares — an estimated $5.26M sold.

Kent Lake Capital first reported a position in AMED in Q3 2021 and held it in 3 quarters. The position peaked at $5.26M in Q2 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Kent Lake Capital reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Kent Lake Capital sold 50,000 Amedisys shares in Q3 2022, an estimated $5.26M.
  • Kent Lake Capital first reported a position in Amedisys in Q3 2021 and held it in 3 quarters.
  • Kent Lake Capital's Amedisys position peaked at $5.26M in Q2 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Kent Lake Capital's 13F filing for Q3 2022, filed 14 Nov 2022.